Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma

被引:0
|
作者
Tao Yan
Fang Liu
Jiajia Gao
Haizhen Lu
Jianqiang Cai
Xiaohang Zhao
Yulin Sun
机构
[1] Chinese Academy of Medical Science & Peking Union Medical College,Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[2] Chinese Academy of Medical Sciences & Peking Union Medical College,State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[3] Chinese Academy of Medical Science & Peking Union Medical College,Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[4] Chinese Academy of Medical Science & Peking Union Medical College,Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
来源
关键词
Liver cancer; Prognostic factor; RuvB-like 2; Regulation; Mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
    Yan, Tao
    Liu, Fang
    Gao, Jiajia
    Lu, Haizhen
    Cai, Jianqiang
    Zhao, Xiaohang
    Sun, Yulin
    [J]. CANCER CELL INTERNATIONAL, 2019, 19 (01)
  • [2] Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
    Zhang, Zhen-Hai
    Wu, Ya-Guang
    Qin, Cheng-Kun
    Rong, Zhong-Hou
    Su, Zhong-Xue
    Xian, Guo-Zhe
    [J]. ONCOLOGY LETTERS, 2014, 8 (05) : 2160 - 2164
  • [3] Down regulation of TROP-2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients
    Sin, Sarah T. K.
    Li, Yan
    Liu, Ming
    Yuan, Yun-Fei
    Ma, Stephanie
    Guan, Xin-Yuan
    [J]. HEPATOLOGY COMMUNICATIONS, 2018, 2 (11) : 1408 - 1414
  • [4] Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage
    Wang, Dong
    Wang, Zhi-Ming
    Zhang, Sai
    Wu, Hai-Jun
    Tao, Yi-Ming
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (06) : 2017 - 2028
  • [5] Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients
    Shi, Zhiyong
    Liu, Jie
    Yu, Xiaohe
    Huang, Jian
    Shen, Shuqun
    Zhang, Yongshun
    Han, Rongli
    Ge, Naijian
    Yang, Yefa
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (01) : 211 - 217
  • [6] Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients
    Zhiyong Shi
    Jie Liu
    Xiaohe Yu
    Jian Huang
    Shuqun Shen
    Yongshun Zhang
    Rongli Han
    Naijian Ge
    Yefa Yang
    [J]. Annals of Surgical Oncology, 2016, 23 : 211 - 217
  • [7] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Ha, Sang Yun
    Song, Dae Hyun
    Hwang, Soo Hyun
    Cho, Soo Youn
    Park, Cheol-Keun
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 171 - 177
  • [8] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Sang Yun Ha
    Dae Hyun Song
    Soo Hyun Hwang
    Soo Youn Cho
    Cheol-Keun Park
    [J]. Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 171 - 177
  • [9] High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma
    Fei, Zai-Yi
    Wang, Wei-Si
    Li, Su-Fen
    Zi, Jia-Ji
    Yang, Li
    Liu, Ting
    Ao, Song
    Liu, Qian-Qian
    Cui, Qing-Hua
    Yu, Min
    Xiong, Wei
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1291 - 1304
  • [10] High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
    Xu, Wenxiong
    Huang, Yanlin
    Mei, Yongyu
    Zhang, Yeqiong
    Luo, Qiumin
    Zhu, Shu
    Peng, Liang
    Gao, Zhiliang
    Liu, Ying
    Li, Jianguo
    [J]. CURRENT ONCOLOGY, 2022, 29 (11) : 8650 - 8667